Skip to main content
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.05
-0.01 (-0.20%)
Dec 5, 2025, 4:00 PM EST - Market closed

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $6.31M in the twelve months ending September 30, 2025, down -36.36% year-over-year. In the year 2024, Taysha Gene Therapies had annual revenue of $8.33M, down -46.07%.

Revenue (ttm)
$6.31M
Revenue Growth
-36.36%
P/S Ratio
238.08
Revenue / Employee
$86,438
Employees
73
Market Cap
1.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

TSHA News

More News